Seize the opportunities offered by RNA therapies and propel your business forward by investing in cutting-edge technologies. As part of AReNA – Québec’s RNA Hub, we are pleased to support the launch of a call for projects aimed at fostering the development of innovative technologies serving the RNA therapy sector.This program, funded by the Ministry…
Announcement BOSTON, June 16, 2025 – CQDM is proud to announce the funding of two collaborative research projects focused on the development of RNA-based therapies. Unveiled during the BIO International Convention in Boston, in the presence of Mr. Christopher Skeete, Minister for the Economy, Minister Responsible for the Fight Against Racism and Minister Responsible for…
Announcement BOSTON, June 17, 2025 – CQDM is proud to announce the addition of three leading Japanese pharmaceutical companies—Daiichi Sankyo Co., Ltd., Ono Pharmaceutical Co., Ltd., and McQuade Center for Strategic Research and Development (MSRD), an indirect subsidiary of Otsuka Pharmaceutical Co., Ltd.—to its growing biopharmaceutical consortium. This strategic expansion strengthens CQDM’s industry reach and reinforces…
A New Chapter Begins at CQDM Montreal, June 11, 2025 — Last night, CQDM paid a heartfelt and grateful tribute to its outgoing President and CEO, Diane Gosselin, co-founder of the organization, as she prepares to retire. Held in the presence of our committee members and many key players from the life sciences ecosystem, the…
CQDM and the Centre for Probe Development and Commercialization (CPDC) are pleased to announce a strategic initiative to support the development of next-generation radiopharmaceuticals in Canada. This collaboration represents a unique opportunity to align Canada’s strengths and global expertise in this expanding field. Together we are initiating a collective effort that will foster innovation and…
Announcement Montreal, May 14, 2025 – CQDM is proud to announce the funding of an innovative artificial intelligence (AI) project aimed at developing targeted therapies for various forms of cancer, alongside companion diagnostic tests designed to enhance patient selection in clinical settings. Valued at nearly $1.8 million, the initiative is led by two fast-growing Quebec…
Announcement Montreal, May 13, 2025 – CQDM and l’Oncopole, pôle cancer du FRQ-santé, are proud to announce the funding of a collaborative research project as part of the Call for collaborative research projects on precision care in oncology. This project aims to evaluate the effectiveness of a radiopharmaceutical anti-cancer therapy, that can both diagnose cancer…
Announcement MONTREAL, May 7, 2025 – CQDM and the Brain Canada Foundation are proud to announce the funding of a research project to identify new chemical compounds with the potential to treat mental health disorders. This project, worth over $1.1 million, is made possible by a $200,820 grant from the Government of Quebec, awarded by…
Announcement MONTREAL, April 30 2025 – CQDM and the CHU Sainte-Justine are proud to announce the creation of the Centre d’expertise sur les maladies rares médiées par le complément (here after the Centre d’expertise), a translational research initiative aiming to revolutionize comprehension, diagnosis and treatment of rare diseases. This project, announced today, boasts a first…
As part of our partnership with Conscience, CQDM is proud to co-host a panel at EFFERVESCENCE 2025, the must-attend life sciences event in North America.🎤 Panel: Building the Future Together – Open Science in Drug DevelopmentThis discussion will bring together Matt Goddeeris (Every Cure), Sébastien Giguère (Valence Discovery), Jason Karamchandani (C-BIG Repository, McGill University), and…